<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Soluble interleukin 2 receptor (SIL-2R) and interleukin 1-B (IL-1B) levels in peripheral blood were assayed by enzyme-linked immunoabsorbent method in 25 patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease and in 20 healthy controls </plain></SENT>
<SENT sid="1" pm="."><plain>Eighteen patients suffered from active <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease and 6 patients had severe disease manifestations </plain></SENT>
<SENT sid="2" pm="."><plain>SIL-2R levels were followed for a period of 16 months and were correlated with disease activity </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> the patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease the levels of SIL-2R and IL-1B were significantly higher than their control, 958 +/- 712 vs. 404 +/- 119 u/ml (P &lt; 0.001) for SIL-2R and 639 +/- 741 vs. 59 +/- 53 pg/ml (P &lt; 0.001) for IL-1B </plain></SENT>
<SENT sid="4" pm="."><plain>No correlation was found between disease activity and severity and the levels of SIL-2R and IL-1B </plain></SENT>
<SENT sid="5" pm="."><plain>It is suggested that levels of SIL-2R and IL-1B are elevated in patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease but do not serve as disease activity markers </plain></SENT>
</text></document>